The objectives of this paper are to describe ecstasy use patterns among young adult (18-25 years) 
INTRODUCTION
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other drugs, a pattern with ecstasy as the primary drug is less common than one in which ecstasy is added to an already existing repertoire (Forsyth, 1996; Hammersley et al., 1999; Schifano et al., 1998; Solowij et al., 1992; Theall, Greene, Kachur, & Elifson, 2001) . Frequently mentioned reasons for poly-drug use among ecstasy users are to enhance the high (Forsyth, 1996; Hammersley et al., 1999; Schifano et al., 1998; Solowij et al., 1992) and to soften the processes of coming down from a high (Forsyth, 1996; McDermott, 1993; Riley, Jame, Gregory, Dingle, & Cadger, 2001; Solowij et al., 1992) . Some ecstasy users may also coadminister dietary supplements in an attempt to protect themselves from neurotoxicity (McCann & Ricaurte, 1993) .
In this paper we aim to begin closing the gap in our knowledge of ecstasy users. As a first step we focus on the current use patterns among active ecstasy users. Current is defined as use in the past 90 days. The objectives are to describe the patterns of ecstasy use among a sample of young adult (18-25 years) ecstasy users and to compare and contrast patterns and reported effects according to the frequency (number of days used in the last 90 days) and intensity (typical number of pills taken per sitting) of ecstasy use. We also examine the degree of poly-drug use and the effects of ecstasy use and how these relate to the frequency and intensity of use.
METHODS

STUDY PROCEDURES
Between September 2002 and April 2004 , a cross-sectional survey was conducted among 261 current, out-of-treatment ecstasy users between the ages of 18 and 25 in Atlanta, Georgia. To be eligible, respondents had to have used ecstasy at least three times in the past 90 days (on separate occasions), not be in a drug treatment or other institutional setting, and not be intoxicated or otherwise cognitively impaired at the time of interview. The frequency of use criterion was implemented to allow for the recruitment of light, medium, and heavy users.
Initial participant recruitment involved the community identification (CID) process, a mapping method to record epidemiological indicators of the prevalence of ecstasy use (e.g., from emergency rooms, law enforcement, and drug treatment), expert opinions (e.g., local public health officials), and ethnographic information from local researchers (Tashima, Crain, O'Reilly, & Sterk-Elifson, 1996) . As the CID process progresses, including its ethnographic mapping and targeted sampling (Sterk, 1999; Watters & Biernacki, 1989) , the recruitment focus increasingly becomes targeted. The use of the CID process also allowed us to become familiar with the social ecology of the ecstasy scene, including the different types of users, the various social settings of use, and the associated behaviors and interaction patterns. The CID process is especially effective when studying "hidden" populations of which the parameters are unknown. The field team consisted of four women, three White and one African American, and five men whose racial/ethnic background was African-American (n=2), White (n=2) and Latino/a. Using a short form, potential respondents were screened either in the setting where they were recruited such as at clubs, raves, near college dorms or off-campus student housing, and at public settings such as parks. Passive recruitment, involving the posting of flyers in local clubs and venues, colleges and universities, coffee shops, and on the street in targeted areas of the city with heavier concentrations of young adults, was also utilized. Potential respondents who called the project phone line listed on the flyers initially were screened over the phone using the same short form. Once a potential respondent was identified as eligible, the staff member would describe the study and time required to participate. The two most common reasons for ineligibility were not having used ecstasy at least three times in the past 90 days or not being between 18 and 25 years.
Interviews were scheduled with interested individuals who passed the screening. The interviews took place at a mutually convenient location such as one of the project offices, the respondent's home, a local restaurant or coffee shop, community centers, or the interviewer's car. Prior to the interview, a follow-up screening with a specific focus on ecstasy was conducted. For example, questions were asked about the local price of ecstasy, the local ecstasy taxonomy, and the ecstasy high. Very few individuals failed the second screening.
Once identified as eligible, additional information was provided on the nature of the study, the time required, and the informed consent and other confidentiality procedures. The consent form and procedures were approved by the Emory and Georgia State University Institutional Review Boards. The respondents and the interviewer each retained a copy of the signed consent form.
Data collection involved an interviewer-administered computerized interview. The average length of time to complete a quantitative interview was two hours (range from 1 to 3.5 hours). Respondents were reimbursed $25 for their participation.
MEASURES
Data were collected using a structured survey developed specifically for the study, based on existing validated instruments used in the field as well as on pilot research among a similar population of ecstasy users. Sociodemographic characteristics included gender, age, race/ethnicity, education, relationship status, sexual orientation (heterosexual, homosexual, bisexual), employment and student status, income, and self-ranking of socio-economic status (lower, middle or upper), unstable living situation (defined as living on the streets, car, shelter, transitional housing or hotel versus in own home, someone else's home, dormitory, or public housing), the number of children, and victimization or abuse history (lifetime and past year sexual, physical, and emotional abuse by anyone). Both traditional/ objective measures of socioeconomic status (e.g., educational attainment, income, and professional/occupational status) as well as subjective measures (self-identified SES) were measured. The SES was utilized as a proxy measure because the sample consists of young adults. Given their life stage, their own SES may not have fully developed and they may rely on their parent's SES, which may be misleading. We realize that both indicators of SES have limitations, but we felt that the subject measure better captured the respondents' sense of their own SES.
Questions on current ecstasy use patterns covered items regarding the last 90 days: number of days ecstasy was used, route of administration (oral, intranasal, smoke, inject), settings of use (own place -no party, friend's place -no party, at party, club or rave,' at music concert, and other), the presence of others (alone, with other people but respondent is the only one using ecstasy, with other people, some of whom are using ecstasy, with other people and most of them are using ecstasy, and with other people and all of them are using ecstasy). Additional questions involved the amount used (including booster doses and binge patterns), the length of the ecstasy high and the change in the high over time, the amount paid for ecstasy, and physical and psychological effects believed to be due to ecstasy use. Binge use was defined as continuous use for at least 24 hours, although no specification was given for time between doses. Years using ecstasy was calculated as the time between the age at first use of ecstasy and the respondent's current age, with no assumption made of continued or sporadic use over time.
Illegal poly-drug use was measured by the number of days used in the last 90 days for amphetamines, crack/freebase cocaine, powder cocaine, GHB, hallucinogens (including LSD), heroin, ketamine, marijuana, methamphetamine, OxyContin, other unprescribed opiates, and unprescribed pills (e.g., Valium®, Xanex®). History of drug or alcohol treatment was also assessed, including treatment for ecstasy use. Lifetime and current tobacco and alcohol information was obtained, such as questions on age at first use, lifetime use, recent smoking and drinking (e.g., daily consumption, amount in last week), average number of cigarettes per day in the past year, average number of drinks per month, the number of drinks per sitting, and problems associated with alcohol use. In the present analysis, daily consumption of cigarettes and alcohol as well as the average number of cigarettes per day in the past year and average number of alcoholic drinks per month was examined.
Because no standard definition of light, medium and heavy ecstasy use is available, we defined these levels of use based on the frequency of ecstasy use-the distribution of the number of days that the drug was used in the last 90 days, using the first and ninth deciles modified based on calendar time as cutoffs for light and heavy use, respectively. The median number of days of ecstasy use in the last 90 WINTER 2006 205 days was 10. The first decile was 5 days, while the 9th decile was 30 days. If a respondent used ecstasy every weekend on both nights for the last three months (90 days), that would correspond to 24 days of use in the last 90 days. We chose 25 days as an upper cutoff value for "heavy" (most frequent) use to correspond to use every weekend (all weekend) or more in the last 90 days. We chose the first decile (5 days) as "light" (least frequent) use, which was also half the median. Using these cutoff values, the majority of respondents used ecstasy between 6 and 25 days in the last 90 days (65%), 22% used ecstasy 3-5 days in the last 90, 13% used ecstasy more than 25 days in the last 90 days.
We defined intensity of use based on the typical number of pills taken per sitting -one, two, or more than two. Approximately half of respondents (49.4%) said the average number of pills taken per sitting was one, 35.6% reported an average of two pills, and 14.9% reported typically consuming more than two pills.
In our own previous research and pilot data, we found that individuals using with the greatest frequency were not the same as those using with the greatest intensity (number of pills per sitting), and we have identified very intense users who do not use ecstasy very frequently and vice versa. Furthermore, each (using frequently or using more intensely) may result in their own physical, pharmacological, psychological, and behavioral effects. Therefore the two measures (frequency and intensity) were kept separate in all analyses, rather than creating an overall summary of frequency/intensity.
STATISTICAL ANALYSES
The majority of analyses in the present study are descriptive in nature. Where applicable, one-way ANOVA or Mann-Whitney U test, or Pearson's correlation was used to examine differences in continuous variables. The Likelihood Ratio chi-square or Fisher's Exact test of independence were used to examine differences in categorical variables. Alpha level was set at 0.05 for all analyses. Bonferroni adjustments were made for multiple testing.
RESULTS
STUDY SAMPLE
As shown in Table 1 , the sample in the present analysis consists of 261 individuals, 183 men (70.1%) and 78 women (29.9%). The median age of respondents was 21 (range 18-25). The majority reported having a high school education (39.1%) or higher (some college/in college) (37.6%). A little more than half of the sample identified as White (51.3%), 34.5% as African American, 2.7% as Latino/a, and 11.5% as other, including American Indian, Asian Indian, Asian, and Philippino. History (ever) of sexual or physical abuse (% yes) 162 62.10 Experienced sexual or physical abuse in past year (% yes) 64 24.52 "Totals and percentages may not reflect overall total (261) due to missing responses. "Use of more than one illegal drug in the past 90 days. 'Defined as currently living in a transitional house/halfway house, shelter, hotel, or on the streets/homeless.
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The majority (81.2%) of the respondents self-identified as heterosexual, 9.2% as gay or lesbian, and 9.6% as bisexual. Nearly 40% of the sample was single, never married, and not currently in a relationship. Twenty-five percent of respondents said they were in a steady relationship but did not live with their partner, and an additional 16% lived with a partner. Almost three fifths (59.4%) of respondents with a partner reported that their current steady or casual sex partner used drugs.
Approximately 26% were legally employed full time and 30% part time. One quarter of the sample was in the service industry (25.7%), followed by sales (21.5%) at the time of interview. Thirty-six (13.8%) of respondents were currently in school or training. The median past 90 day income of the sample was $3,050 (range $0-9,700). In addition to the standard measure of socioeconomic status (SES), we asked the respondents to self-identify their SES. Given the fact that all are young adults, educational attainment, income, and professional status may inadequately reflect their SES. Overall, 19.5% of respondents considered themselves in the upper socioeconomic status bracket.
CURRENT ECSTASY USE
Approximately one fifth of the respondents (21.8%) considered ecstasy their drug of choice. Table 2 presents information on current and past ecstasy use patterns. The median number of years using ecstasy among respondents was 3 (range < 1 to 11 years). The median number of days that ecstasy was used in the last 90 days was 10 (range 3 to 90 days). The majority of the respondents (65%) were "medium" users who took ecstasy between 6 and 25 days in the last 90 days, 22% were "light" users who took ecstasy 3 to 5 days in the last 90 days, and 13% were "heavy" users who took ecstasy more than 25 days in the last 90 days. Daily use was reported by only one respondent and, consistent with previous studies, appears to be uncommon among ecstasy users (Forsyth, 1996; Hammersley et al., 1999; Parrott, Milani, Parmar, & Turner, 2001; Solowij et al., 1992) . There was no difference in the number of days of ecstasy use according to gender, sexual orientation, income, employment, or education. Differences (p < 0.05) were found according to race (with White users reporting a greater number of days of use), age (with younger users reporting fewer days of use in the last 90 days), and self-ranked SES (with those considering themselves in the upper SES bracket reporting fewer days of use). In comparison, respondents who used with greater intensity at each sitting (i.e., greater average number of pills per sitting) were more likely (p < 0.05) to be younger, White, and to consider themselves in the upper SES bracket than those who reported fewer pills taken per sitting. They were also more likely to report having an illegal job and were less likely to be single (data not shown). ,.0 -'g 'g r.,
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All respondents (100%) reported taking ecstasy orally in the past 90 days, 29.1% reported intranasal (snorting) use, 6.1% reported smoking ecstasy, and 1.1% reported injecting the drug in the past 90 days. The most common setting for use in the last 90 days was at a party, club, or rave (85.4%). The median hours of the ecstasy high experienced, before coming down, was 4 (range 1 to 36 hours).
Many respondents (-70%) also reported taking a booster dose of ecstasy when using the drug, with 14.9% reporting that they always take a booster when they use ecstasy. Seventy-one respondents (27.2%) reported never taking a booster dose of ecstasy. Among those who do take booster doses, 46.7% believe that the booster enhances the ecstasy high, 67.0% said that the booster makes the high last longer, and 10.3% said that the booster cuts down on negative aftereffects of ecstasy use. The typical booster dose was one pill (47.1% of those who have taken a booster); 14.2% take less than one pill and 11.5% take more than one pill as a booster dose.
Ninety-four respondents (36.0%) reported ever having binged on ecstasy, defined as reusing the drug continuously for 24 hours or more. The median longest amount of time (hours) spent binging was 48 hours (range 24 to 168 hours). Sixty-four (24.5%) respondents reported binging on ecstasy in the past year, with the median number of times as 3 (range 1 to 200 times). Twelve of the 64 (18.8%) who binged in the last year said they binge about once a month or more frequently.
The majority of respondents reported usually using ecstasy when others around are also using. Most respondents reported having at least one close friend who has ever used ecstasy. The median greatest amount paid for a pill, tablet, or capsule of ecstasy was $25 (range $1 to $60), while the median least amount paid was $10 (range $1 to $25).
POLY-DRUG USE
Poly-drug use was reportedly common among respondents in this sample. Only 21 respondents (8.1%) preferred to use ecstasy alone. Almost half (48.7%) preferred to use marijuana while getting high on ecstasy. Alcohol (10.7%) and hallucinogens (6.1%) were not as common as expected, or at least they were not the preferred other drug to use while using ecstasy. Only 8 (3.0%) respondents reported usually using ecstasy alone, with no other people.
Forty-six respondents (17.6%) reported no additional drug use to aid in coming down from the ecstasy high. More than half (52.1%) reported marijuana as their preferred drug used to come down from ecstasy; 8.0% reported alcohol and 4.9% tobacco, Surprisingly, some respondents preferred stimulants to come down from the ecstasy high (e.g., 2.6% powder cocaine, 5.3% methamphetamine). Table 3 shows the amount (proportion and number of days) of noncurrent or nonsimultaneous illegal poly-drug use by the three frequency categories of ecstasy use. Only five respondents reported no drug use other than ecstasy in the last 90 days. In the entire sample, marijuana was the most commonly reported illegal drug used in the last 90 days in addition to ecstasy. Substantial proportions of respondents reported using powder cocaine (37.2%), hallucinogens/LSD (29.1%), methamphetamine (36.0%), unprescribed opiates (other than OxyContin) (19.2%), and unprescribed pills (31.0%). Approximately 13% of respondents reported using amphetamines No use of another illegal drug in the last 90 days; all 5 were current cigarette smokers and alcohol drinkers. p < 0.05, based on likelihood ratio chi-square or Fisher's exact test comparing % using the various drugs by the frequency of ecstasy use (light, medium, heavy).
(13.4%) or ketamine (13.4%), and 6% reported the use of crack cocaine (6.1%), GHB (6.5%), or OxyContin (6.9%) in the last 90 days.
Significant differences in the use ofhallucinogens/LSD, heroin, and unprescribed pills were found according to the frequency of ecstasy use. The most frequent ecstasy users were less likely to have used hallucinogens (12.1%) and unprescribed pills (12.1%) in the last 90 days compared to medium (30.6% hallucinogens, 32.9% pills) or light (34.5% hallucinogens, 36.2% pills) users. However, among those who used unprescribed pills, respondents in the heavy ecstasy-using category had a higher medium number of days using unprescribed pills (16 of 90 vs. 4 of 90 for both medium and light users). The median number of days using hallucinogens was somewhat similar among the three categories of ecstasy use. Heavy ecstasy users were more likely to have used heroin (15.2%) than medium (5.9%) or light (3.5%) users, and among those who used heroin, the medium number of days using was significantly higher among heavy ecstasy users (75 of 90 days vs. 38 and 25 for medium and light users, respectively).
PHYSICAL AND PSYCHOLOGICAL EFFECTS OF ECSTASY USE
Reported physical and psychological effects of ecstasy use are presented in Table  4 . More than one half of the respondents reported a variety of physical effects of ecstasy use, most commonly jaw clenching or biting (82%), a heightened sense of touch (81.6%), increased heart rate (80.1%), dehydration (76.3%), elevated body temperature (75.1%), alertness (74.3%), desire to be in motion (72.0%), and feeling overheated (67.4%). Commonly reported psychological effects included feeling at peace (82.8%), feeling close to others (78.5%), a sense of well-being (77.8%), and positive self-esteem (76.3%). Approximately one third attributed anxiety (33.7%), depression (36.4%), or paranoia (29.9%) to their ecstasy use.
Substantial proportions of respondents reported symptoms of ecstasy dependence or abuse in the past 12 months including spending a great deal of time using, getting, or getting over the effects of ecstasy (42.9%); using larger amounts of ecstasy or used for longer periods of time than intended (44.4%); finding that the same amount of ecstasy had less effect than before (54.4%); or intentionally stopping or cutting down on their ecstasy use (51.7%).
Ten respondents (3.8%) reported that they had sought treatment or counseling for ecstasy use in their lifetime, and 3% were admitted to an emergency room for ecstasy use.
DIFFERENCES ACCORDING TO FREQUENCY OF USE
Heavy ecstasy users were more likely to report that ecstasy was their drug of choice (39.4%) compared to medium (20.0%) or light users (17.2%). We identified no difference in the median number of years using ecstasy according to current Table 2 ). However, there were differences in the age at first use of any legal or illegal drug according to frequency of ecstasy use: more frequent ecstasy users reported an older age when initiating drug use. Heavier or more frequent users were also significantly more likely to have used ecstasy at their own place or a friend's place, with no party going on, and in other settings. They were also significantly more likely to have ever binged, to have binged in the past year, and to binge about once a month or more compared to less frequent users. There was no difference in the amount of pills taken during a binge or the amount of time (hours) binging according to frequency of use.
A significantly greater proportion of respondents reporting very frequent (heavy) use also reported usually using ecstasy alone compared to those who used less frequently in the past 90 days. However, there was no difference in the amount of close friends who ever used ecstasy according to frequency of use, with both frequent and less frequent users reporting similar proportions of friends who have used. The amounts paid for a pill, tablet, or capsule were similar across all frequency of use categories.
There were no significant differences in reported physical or psychological effects of ecstasy use according to frequency of use (as shown in Table 4 ). There were significant differences in symptoms of abuse or dependence according to frequency of use. Compared to respondents who used less frequently, however, greater proportions of more frequent ecstasy users reported spending a great deal of time using ecstasy, getting ecstasy, or getting over its effects; using larger amounts or using for longer periods of time than intended; and wanting to cut down or control use or trying to cut down on use.
DIFFERENCES ACCORDING TO INTENSITY OF USE
Results based on comparisons according to intensity of use, i.e., typical number of pills taken per setting, are not shown in the tables; however, differences between intensity and frequency of use were identified. In comparison to frequency of use, there was no significant differences in reported drug of choice based on intensity of ecstasy use (i.e., more intense users were not more likely to report ecstasy as being their drug of choice). Similar to frequency categories, there were no statistically significant differences in years using ecstasy according to intensity of ecstasy use but differences were identified in the age at first use of any legal or illegal drug. Unlike more frequent users (who reported an older age at first drug use), however, more intense users reported a younger age at first drug use.
There was no difference in the number of days of ecstasy use according to intensity of use, but significant differences in the route of ecstasy use were identified. Respondents using with the greatest intensity (i.e., typically more than two pills per sitting) were significantly more likely to report snorting and smoking ecstasy in the past 90 days. Unlike frequent users, who were more likely to have used ecstasy in other settings, more intense users were less likely to report use in other settings or at a music concert in the past 90 days.
The reported time lapse to experience the high did not vary across ecstasy intensity categories. Similar to frequency of use groupings, there was no significant difference in the likelihood of taking a booster dose according to intensity of use but, as expected, more intense users reported a greater typical booster dose than less intense users. The likelihood of lifetime or current binging also differed according to intensity of use, with more intense users being more likely to binge. Compared to their peers, more intense users also reported a greater amount of pills taken during a binge and more hours spent on binging.
Similar to frequency of use categories, there were no significant differences in the preferred drug to take while on ecstasy or while coming down from ecstasy according to intensity of use. A greater proportion of more intense users reported preferring hallucinogens when taking ecstasy and nonprescription pills when coming down from ecstasy.
A significant difference in the nonsimultaneous use of other illegal drugs also was found according to intensity of ecstasy use. Respondents who reported the most intense use of ecstasy were significantly more likely to report the use of powder cocaine, heroin, OxyContin, other nonprescription opiates and other nonprescription pills, hallucinogens, methamphetamine, and ketamine.
Although reported physical or psychological effects of ecstasy use were similar across levels of frequency, there were significant differences in effects according to intensity of use (data not shown). More intense users were more likely (p < 0.05) to report experiencing an upset stomach, visual distortions, hallucinations, hearing things differently, jaw clinching, dehydration, increased heart rate, and memory problems. They were less likely to report feeling alert compared to those who used less intensely. There were also significant differences in symptoms of abuse or dependence according to intensity of ecstasy use, with more intense users more likely to report spending a great deal of time using ecstasy, getting ecstasy, or getting over its effects; using larger amounts or using for longer periods of time than intended; finding that more ecstasy had to be taken to achieve the same effect; and getting sick from ecstasy use. They were less likely to report wanting to cut down or control use or trying to cut down on use.
DISCUSSION
The users in this sample appear to represent a fairly nonhomogenous group, based on both socio-demographic differences as well as patterns of ecstasy use.
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Data on the levels of ecstasy use show that it is less sporadic than often is assumed and also that it is common for users to take more than one pill, either when getting high or when "boosting." Among the respondents, White users reported more days of use during the past 90 days (p < 0.05) than users from other racial/ethnic groups. Frequently, ecstasy use is viewed mainly as a "White drug." Although recent studies, including our own research (Boeri, Sterk, & Elifson, 2004) , show ecstasy users to have diverse racial and ethnic backgrounds it is important to recognize the differences in patterns of use according to cultural background as well as other characteristics. Younger users reported fewer days of use in the past 90 days. This is interesting given the fact that ecstasy use often is associated with younger users. Finally, those respondents who subjectively ranked themselves in the higher socioeconomic strata tended to report using less days during the past 90 days. We used an objective as well as subjective measure of SES given the young adult status of the respondents. Whereas their own educational attainment, income, and professional status may still be evolving, it also will be misleading to apply their parents' SES. Given the respondents' difficulty in providing data on their income, we opted to use their subjective assessment of SES as a proxy measure. Analogous to assumptions regarding ecstasy as a drug mainly used by Whites, the assumption often is made that it is a middle-class drug. Our findings challenge this notion. In addition to these socio-demographic differences, numerous differences were identified based on patterns of use, i.e., the frequency or intensity of ecstasy use. Frequency and intensity of ecstasy use may impact the route of administration. Clearly, oral ingestion remains the most common route. Nevertheless snorting, smoking, and injecting ecstasy were reported and were more common among those who used with the greatest frequency or intensity (with the latter reaching statistical significance). These findings show not only the importance of recognizing the various ways in which ecstasy is taken since it is often assumed to be orally administered, but also the need to link routes to use patterns. If users are injecting the drug, this presents a more significant problem with respect to parenternally transmitted infections and other consequences of injection drug use, particularly if they are using with greater frequency or intensity.
Differences in the reported physical and psychological effects of ecstasy use did not differ by the frequency of use (number of days ecstasy was used in the past 90 days). When exploring the intensity of use, however, more intense users were more likely to report effects such as an increased heart rate, an upset stomach, dehydration, visual distortions, and hallucinations. These findings suggest that many of the effects of ecstasy use are more likely to be linked to intensity rather than frequency of use. However, both more intense and more frequent users experienced more symptoms of ecstasy abuse or dependence than the less intense and frequent users.
JOURNAL OF DRUG ISSUES
Use patterns also differed by the context or setting of use. Studies have shown ecstasy use to have moved beyond raves. Among the respondents in our study, we found that the more days a person used ecstasy during the past 90 days, the more likely they were to do so at their own place or at a friend's place -both in a nonparty atmosphere. Raves and music concerts appeared to be less favorable settings among those who used more frequently and with higher levels of intensity. This could be a result of increased controls on ecstasy and other club drug use in public venues, or continued spread of ecstasy out of the "raving" or clubbing demographic, or continued use by individuals who club less frequently but continue to use ecstasy in other settings. Despite the view of ecstasy as a "social" drug, we also found that the intensity of use was impacted by others being present, with users who reported typically taking two or more pills to get high being more likely to do so when around others who also use drugs. It is unclear to what extent peer pressure might influence the amount of pills taken.
Moreover, the use of a booster dose and binging needs to be considered, given the possible physical and psychological effects of ecstasy (Steele, McCann, & Ricaurte, 1994) and the potential for increased consequences with heavier or more intense use. More than one third of the respondents reported having ever binged on ecstasy. More frequent and intense users were more likely to have binged. Furthermore, the majority of the respondents reported taking a booster, with 14.9% indicating that they take a booster pill every time they get high on ecstasy. Similar findings have been reported in other studies (McCann & Ricaurte, 1993; McGuire, Cope, & Fahy, 1994) . As shown, the main reasons for taking a booster are to extend and to enhance the high. Those respondents who tended to take more than one pill when using ecstasy also were more likely to indicate using a booster dose. The number of days a person used in the past 90 days was not related to booster behaviors.
Another salient dimension of the current use patterns among ecstasy users is poly-drug use. The vast majority of respondents in this sample were poly-drug users, similar to other populations of individuals who use ecstasy (Boys et al., 1999; Pedersen & Skrondal, 1999; Schifano et al., 1998; Topp, Hando, Dillon, Roche, & Solowij, 1999; Winstock et al., 2001) . Only approximately one fifth (22%) of the respondents in our study listed ecstasy as their primary drug of choice. Those who used ecstasy most frequently were almost twice as likely to identify ecstasy as their primary drug of choice than those who used less often. Simultaneous poly-drug use (using ecstasy while using another drug) was common as was the use of another drug to come down from the ecstasy high and other current drug use. The use of other drugs while on or while coming down from ecstasy did not differ significantly by frequency and intensity of use, although several nonstatistically significant WINTER 2006 221 differences were found. Although our data provide insufficient detail, it appears that the illicit use of prescription drugs is common among ecstasy users. Given the amount of simultaneous and other poly-drug use reported in this sample, it seems appropriate to refer to these respondents as drug users who also use ecstasy.
The findings of high levels of ecstasy use and the common practice of poly-drug use are a cause for concern that warrants further investigation. Animal studies have shown that MDMA-associated neurotoxicity is dose dependent (McCann, Ridenour, Shaham, & Ricaurte, 1994; Morland, 2000; Steele et al., 1994) . Dehydration, commonly reported among ecstasy users, can lead to heat exhaustion, kidney and cardiovascular system failure (including heart attack or stroke), and has also led to seizures in some users (Steele et al., 1994) . It is important to teach ecstasy users to recognize dehydration and to take action to reduce any harm from occurring. It also will be important for users to be familiar with cross-reactions between different drugs that might be taken and the unique effects of each of these drugs. Furthermore, many pills, capsules, or tablets sold as ecstasy may or may not contain MDMA (Spruit, 2001) . Such poly-drug use or even involuntary exposure to a variety of substances (e.g., using pills with unknown content) poses a problem for users as well as researchers, making it difficult to isolate the physical, psychological, and behavioral effects of MDMA.
Despite important findings, limitations to our study should be considered. The method of recruitment (due to an unknown population of drug users), study design, and cultural and geographic characteristics of this sample limit the generalizability of findings to a wider population. Drawing a representative sample of ecstasy users is hindered by their relatively hidden nature, especially of those who do not use at raves, clubs, or bars. Given the small sample size, coupled with the convenience sampling procedures, reported patterns of ecstasy use may not be representative of all young adult ecstasy users. Furthermore, the study's cross-sectional design makes it difficult to draw causal conclusions.
Most importantly, data utilized were based on self-reports, which may,be affected by recall, social desirability, or additional types of bias. Although a past 90-or 30-day time frame was used for most questions to minimize the possibility of recall bias, other biases may be present. The authors maintain the validity of self-reported data, as numerous studies have included fairly large number of substance users and have noted the accuracy of reported information about use behaviors (Anglin, Hser, & Chou, 1993; Higgins, Budney, Bickel, & Badger, 1995; Needle et al., 1995; Nurco, 1985) . Researchers have also demonstrated the external validity of purposive samples of ecstasy users compared to national population studies (Topp, Barker, & Degenhardt, 2004) .
In conclusion, a better understanding of ecstasy use patterns and combination and poly-drug use among young adults is needed. Based on results of this crosssectional survey, the latter appears to be part a general drug-taking profile -a means to enhance the ecstasy high or a means to cope with the negative side effects when coming down from an ecstasy high. Additional phenomenological and longitudinal quantitative studies would aid in understanding combination use, consequences of combination use and of ecstasy use in general, and drug use career trajectories of ecstasy users. Information from such studies should be used to develop appropriate risk reduction and treatment interventions as well as guide policy decisions.
NOTE
Defined as a typically all-night dance party where techno or electronically synthesized music is played.
